ClosePlease login

Delays in court approval of settlements in their pelvic mesh class actions against US giants Johnson & Johnson and Boston Scientific have been blamed for Shine Lawyers’ 89.39 per cent decline in net profits for 2023.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: Content is protected !!

For information on rights and reprints, contact subscriptions@lawyerly.com.au